Brevel Launches FOAK Facility to Demonstrate Microalgae Protein Fermentation at Commercial Scale

Brevel, an Israeli startup specializing in biomass fermentation to produce microalgae proteins, has launched a demonstration facility in Southern Israel to showcase its fermentation process at a commercial scale for the first time. The company has secured agreements with F&B companies and is actively forming partnerships to develop microalgae protein facilities. With a focus on sustainability and affordability, Brevel's technology uses a unique fermentation process with non-GMO microalgae to produce functional proteins, oils, and fibers.

The company, founded by the Golan brothers, aims to meet the increasing demand for nutritious and sustainable proteins without using agricultural land. Following a successful seed round of $18.5 million, Brevel is preparing to initiate commercial production by early 2025 and plans to produce hundreds of tons of its flagship microalgae protein concentrate for meat and dairy alternatives. The company's CEO will be discussing FOAK facilities and securing offtake agreements at an upcoming industry summit, highlighting the future potential of plant-based proteins.